Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2022 | Investigating the impact of at-home training and tDCS on cognitive function in MS

Leigh Charvet, PhD, New York University Grossman School of Medicine, New York, NY, discusses findings from a sham-controlled study assessing online adaptive cognitive training with transcranial direct current stimulation (tDCS), a form of non-invasive brain stimulation, in patients with multiple sclerosis (MS). 120 patients received a total of 30 sessions of either active or sham tDCS lasting 20 minutes over a period of 6 weeks. A vast majority were able to complete the treatment regimen at home, with a significant number of patients receiving active tDCS reporting an improvement in Brief International Cognitive Assessment in MS (BICAMS) test scores. This interview took place at the ACTRIMS Forum 2022 in West Palm Beach, Florida.

Transcript (edited for clarity)

So this was a randomized sham-controlled trial of tDCS, or transcranial direct current stimulation, which is a type of noninvasive brain stimulation paired with brain training games or adaptive cognitive remediation that’s through a web-based platform using Posit Science’s BrainHQ.

And so the intervention was a six week intervention of 30 sessions of 20 minutes of training, and participants were randomized to active or sham tDCS...

So this was a randomized sham-controlled trial of tDCS, or transcranial direct current stimulation, which is a type of noninvasive brain stimulation paired with brain training games or adaptive cognitive remediation that’s through a web-based platform using Posit Science’s BrainHQ.

And so the intervention was a six week intervention of 30 sessions of 20 minutes of training, and participants were randomized to active or sham tDCS. We enrolled 120 people and we found that the training was very feasible. We had a high rate of completion. Over 92% of the participants completed all the training sessions.

And so this was a completely home-based trial. So really supporting the use for telerehabilitation. And we found a significant benefit for the active versus sham tDCS on cognitive functioning measured by change in BICAMS, or Brief International Cognitive Assessment for MS, measuring change from baseline to study end. And that active tDCS versus sham tDCS led to significantly better training cognitive outcomes.

The overall idea is functional targeting with tDCS for rehabilitation. So if we can boost or potentiate the learning that occurs during a training activity, we can have a stronger and hopefully more durable benefit from that training activity. So that’s broadly the way that we’re evaluating tDCS, both for cognitive and motor rehabilitation.

Read more...

Disclosures

Prof. Charvet reports the following disclosures:
Funding: US Department of Defense & National Multiple Sclerosis Society